Human parotid secretory protein is a lipopolysaccharide-binding protein: identification of an anti-inflammatory peptide domain

被引:34
|
作者
Abdolhosseini, Mahsa [1 ]
Sotsky, Julie B. [2 ]
Shelar, Anuradha P. [2 ]
Joyce, Paul B. M. [3 ,4 ]
Gorr, Sven-Ulrik [1 ,2 ]
机构
[1] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA
[2] Univ Louisville, Sch Dent, Oral Hlth & Syst Dis Res Grp, Dept Periodont Endodont & Dent Hyg, Louisville, KY 40292 USA
[3] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada
[4] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ H3G 1M8, Canada
关键词
Saliva; Endotoxin; SPLUNC2; C20orf70; Antimicrobial peptide; Lipopolysaccharide-binding protein; SPLUNC1; PROTEIN; SALIVARY PROTEIN; GLAND PROTEIN; HOST-DEFENSE; PLUNC; MEMBERS; EXPRESSION; EPITHELIA; CLONING; DESIGN;
D O I
10.1007/s11010-011-0991-2
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Parotid secretory protein (PSP) (C20orf70) is a salivary protein of unknown function. The protein belongs to the palate, lung, and nasal epithelium clone (PLUNC) family of mucosal secretory proteins that are predicted to be structurally similar to lipid-binding and host-defense proteins including bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein. However, the PLUNC proteins exhibit significant sequence variation and different biological functions have been proposed for different family members. This study tested the functional implications of the proposed similarity of PSP to the acute phase protein lipopolysaccharide-binding protein (LBP). PSP was identified in human saliva and was soluble in 70% ethanol, as shown for other PLUNC proteins. PSP binds lipopolysaccharide and can be eluted by non-ionic detergent, but not by urea or high salt. A synthetic PSP peptide, GL13NH2, which corresponds to a lipopolysaccharide-inhibiting peptide from LBP, inhibited the binding of lipopolysaccharide to both PSP and lipopolysaccharide-binding protein. Peptides from other regions of PSP and the control peptide polymyxin B showed no effect on the binding of PSP to lipopolysaccharide. GL13NH2 also inhibited lipopolysaccharide-stimulated secretion of tumor necrosis factor from macrophages. The other PSP peptides had no effect in this assay. PSP peptides had no or only minor effect on macrophage cell viability. These results indicate that PSP is a lipopolysaccharide-binding protein that is functionally related to LBP, as suggested by their predicted structural similarities.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [41] Cell activation of human macrophages by lipoteichoic acid is strongly attenuated by lipopolysaccharide-binding protein
    Mueller, Mareike
    Stamme, Cordula
    Draing, Christian
    Hartung, Thomas
    Seydel, Ulrich
    Schromm, Andra B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (42) : 31448 - 31456
  • [42] Lipopolysaccharide-binding protein: Local expression in bovine extrahepatic tissues
    Rahman, Md. Mizanur
    Lecchi, Cristina
    Avallone, Giancarlo
    Roccabianca, Paola
    Sartorelli, Paola
    Ceciliani, Fabrizio
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2010, 137 (1-2) : 28 - 35
  • [43] Concentrations of serum amyloid A and lipopolysaccharide-binding protein in horses with colic
    Vandenplas, ML
    Moore, JN
    Barton, MH
    Roussel, AJ
    Cohen, ND
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2005, 66 (09) : 1509 - 1516
  • [44] FUNCTION OF THE LIPOPOLYSACCHARIDE-BINDING PROTEIN OF PERIPLANETA-AMERICANA AS AN OPSONIN
    JOMORI, T
    NATORI, S
    FEBS LETTERS, 1992, 296 (03) : 283 - 286
  • [45] Lipopolysaccharide-binding protein is a useful marker for systemic infection on the ICU
    Nierhaus, A
    Frings, D
    Montag, B
    Jung, R
    Schneider, CG
    Suerhoff, N
    Esch, JSA
    INTENSIVE CARE MEDICINE, 2001, 27 : S277 - S277
  • [46] Levels of soluble CD14 and lipopolysaccharide-binding protein in human basal tears
    Ken Fukuda
    Naoki Kumagai
    Teruo Nishida
    Japanese Journal of Ophthalmology, 2010, 54 : 241 - 242
  • [47] Surfactant protein A inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein
    Stamme, C
    Müller, M
    Hamann, L
    Gutsmann, T
    Seydel, U
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 27 (03) : 353 - 360
  • [48] Identification of Porphyromonas gingivalis lipopolysaccharide-binding proteins in human saliva
    Choi, Seulggie
    Baik, Jung Eun
    Jeon, Jun Ho
    Cho, Kun
    Seo, Deog-Gyu
    Kum, Kee-Yeon
    Yun, Cheol-Heui
    Han, Seung Hyun
    MOLECULAR IMMUNOLOGY, 2011, 48 (15-16) : 2207 - 2213
  • [49] The role of lipopolysaccharide-binding protein in modulating the innate immune response
    Zweigner, Janine
    Schumann, Ralf R.
    Weber, Joerg R.
    MICROBES AND INFECTION, 2006, 8 (03) : 946 - 952
  • [50] Structural and Functional Features of a Developmentally Regulated Lipopolysaccharide-Binding Protein
    Krasity, Benjamin C.
    Troll, Joshua V.
    Lehnert, Erik M.
    Hackett, Kathleen T.
    Dillard, Joseph P.
    Apicella, Michael A.
    Goldman, William E.
    Weiss, Jerrold P.
    McFall-Ngai, Margaret J.
    MBIO, 2015, 6 (05):